A carregar...
Therapeutic options for HER-2 positive breast cancer: Perspectives and future directions
During the last 15 years we have witnessed an unprecedented expansion in the drugs developed to target human epidermal growth factor receptor-2 (HER-2) positive breast cancer. Trastuzumab, pertuzumab, ado-trastuzumab emtansine and lapatinib are currently food and drug administration (FDA)-approved f...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4127614/ https://ncbi.nlm.nih.gov/pubmed/25114858 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5306/wjco.v5.i3.440 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|